Suprachoroidal Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for the Regeneration of Glaucomatous Optic Neuropathy: A Preliminary Investigation
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2024, Vol 5, Issue 3
Abstract
Objective: This preliminary research presents clinical findings from patients with advanced Glaucomatous Optic Neuropathy (GON) who underwent transplantation of Umbilical Cord-Derived Mesenchymal Stem Cells (UCMSCs) into the suprachoroidal space. Methods: This prospective, single-center study included 17 eyes of 17 patients diagnosed with GON, who received suprachoroidal UCMSC implantation. Patients were registered if their visual acuity and/or Visual Field (VF) deteriorated despite maintaining good intraocular pressure control with anti-glaucomatous treatments. Evaluations were conducted at baseline, on the first postoperative day and at 1 month, 6 months and 1 year after surgery. Best Corrected Visual Acuity (BCVA), anterior segment and fundus examination, color photography, Optical Coherence Tomography (OCT), Retinal Nerve Fiber Layer (RNFL) analysis, VF testing and Pattern Visual Evoked Potential (PVEP) assessments were performed at baseline and during follow-up visits. Results: All 17 participants completed the 12-month follow-up period. No systemic or serious ocular complications were recorded. The study showed significant improvements in BCVA, VF results, RNFL measurements and PVEP amplitudes at the end of the follow-up period. Conclusion: Although the sample size is limited, suprachoroidal UCMSC therapy appears to be safe, with encouraging improvements. Further studies with larger patient groups and longer follow-up periods are required to assess the impact of stem cell delivery on visual acuity and quality of life in glaucoma patients.
Authors and Affiliations
Ayse Oner1*, Neslihan Sinim Kahraman2
Keywords
Related Articles
- EP ID EP750283
- DOI https://doi.org/10.46889/JRMBR.2024.5302
- Views 61
- Downloads 0
The Future Role of Mesenchymal Stem Cells in Tissue Repair and Medical Therapeutics: Realities and Expectations
Mesenchymal Stem Cells (MSCs); which were first described by Alexander Fridenstein in the 1960s; are heterogeneous, non-hematopoietic, adult multipotent stromal progenitor cells that are capable of self-renewal and dif...
The Application of Transgenesis to Abraham Trembley’s Hydra, an Ancient Animal Model for the Study of Regeneration that has now entered the 21st Century
Developmental biology and regenerative biology began with the studies of Abraham Trembley who was a mathematician. Trembley initiated studies with the freshwater hydrozoan, hydra to determine if the organism was a plan...
Platelet Rich Plasma- Platelet Concentrate Therapy in COPD: An Observational Cohort Study
Objective: Current management of Chronic Obstructive Pulmonary Disease (COPD) is aimed at improving symptoms and preventing exacerbations, yet those treatments cannot alter the natural progression of lung function decl...
Jejunal Atresia with Hirschsprung’s Disease: A Case Report
A rare case of congenital intestinal atresia associated with Hirschsprung disease was reported. A 0-day-old boy who was diagnosed to have intestinal atresia and he underwent intestinal anastomosis. The movement of the...
A Regenerative Interventional Approach to the Management of Degenerative Low Back Pain
Objective: Low back pain has been strongly related to the degenerative process of the spine, especially the degeneration of the intervertebral disc and facet joints. The main procedures for the management of low back pai...